This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Niagen Bioscience, Inc.
Q32024
10/31/2024
Mandeep
Operator
Thank you for standing by. My name is Mandeep, and I'll be your operator today. At this time, I'd like to welcome everyone to the Chromadex third quarter 2024 earnings conference call. All lines will be placed on mute to prevent any background noise. After the speaker's remarks, there'll be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you'd like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Ben Shamsian.
Ben Shamsian
Investor Relations
Investor Relations. You may begin.
Unknown
Thank you.
You're reading a preview of the NAGE Q3 2024 earnings call.
Free account.
Disclaimer